Since the birth of Genentech for decades, the biopharmaceutical industry has seen numerous new technologies and countless new companies. Many of these technologies have been known from the beginning of their birth as revolutionary new breakthroughs in comparison with recombinant DNA, such as gene therapy, such as gene sequencing, gene… Continue Reading Conceit, determination and frustration: Uncovering the mystery of the largest unicorn Moderna
Since RNAi (RNA interference) was first discovered 20 years ago, researchers from both academic institutions and pharmaceutical companies have been hoping to develop this technology into new therapies that can treat diseases, but so far there is no one. Related drugs are listed. Fortunately, however, Alnylam Pharmaceuticals, a pioneer… Continue Reading After 20 years of agitation of RNAi drugs, hope is in sight.
In the decades since Genentech’s birth, the biomedical industry has seen countless new technologies, countless new companies. Many of these technologies have been touted as a revolutionary new breakthrough in recombinant DNA, such as gene sequencing, gene editing and RNA interference. But today, no single technology can revolutionize the pharmaceutical… Continue Reading Conceit, determination and frustration: the unveiling of the biggest unicorn, Moderna